Show notes
In this episode, Dr. Troy Spurrill, compounding pharmacist Bryana Gregory, and Richelle Voth, PA, tackle the recent FDA warning that threatens patient access to desiccated natural thyroid medication. They discuss how this policy shift could impact those with thyroidectomies and autoimmune disorders who depend on this life-saving treatment. The team explores the FDA's new requirement for a biologics license, which could create a market monopoly, raise costs, and eliminate the role of compoundi...